The People’s Republic of China has granted the first patent for a COVID-19 vaccine. This grant was issued by the country’s National Intellectual Property Administration.
The state media reported that the Country’s vaccine specialist CanSino Biologics Inc won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, citing documents from the country’s intellectual property regulator.
In a report in state-owned newspaper People’s Daily, the patent was jointly applied for by a research team with the Academy of Military Sciences and CanSino Biologics Inc., a Chinese high-tech biopharmaceutical company.
Chen Wei, a researcher at the Institute of Military Medicine under the academy, led the team to develop the recombinant COVID-19 vaccine, with the modified defective adenovirus as the vector.
The People’s Daily reported on Sunday that It is the first COVID-19 vaccine patent granted by China. The vaccine was the first in China to be approved to enter clinical trials, in March.
The report confirmed that the vaccine has been verified for safety and immunology, having completed phase-1 and phase-2 clinical trials.
The patent abstract has it that the vaccine shows good immunogenicity in both mouse and guinea pig models. It can induce strong cellular and humoral immune response in a short time. Besides, It can be produced quickly on a large scale to cope with a COVID-19 outbreak.
This month in Saudi Arabia, plans are being made to begin Phase III clinical trials for the CanSino vaccine.
CanSino has said it is also in talks with Russia, Brazil, and Chile to launch Phase III trials in those countries.
The company’s Hong Kong shares rose around 14% in Monday’s morning session while its Shanghai shares rose by 6.6% as of midday.
Recall that the Chinese city of Wuhan went into a then-unprecedented lockdown January 23 – at a time where the virus had killed 17 people and affected more than 400.
It was only after a week that China confirmed that human-to-human transmission of the virus had taken place, something not previously proven.
Wuhan became like a ghost town when it went into lockdown. The city of about 11 million people became entirely cut off from the rest of China, as thousands of people were over the next few months, tested and placed in quarantine.
All large public gatherings were canceled and people were instructed to avoid gathering.
Since July, life has truly started to go back to normal in most parts of China. Cinemas in most places have been permitted to re-open.
Certain parks, libraries, museums have also been allowed to open at half capacity, and larger gatherings also given permission to hold.